Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s share price was up 63% on Thursday . The stock traded as high as $1.50 and last traded at $1.50. Approximately 39,500 shares changed hands during trading, an increase of 1,094% from the average daily volume of 3,307 shares. The stock had previously closed at $0.92.
Idorsia Price Performance
The company’s 50 day simple moving average is $1.41 and its 200 day simple moving average is $2.10.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Recommended Stories
- Five stocks we like better than Idorsia
- 3 Tickers Leading a Meme Stock Revival
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 REITs to Buy and Hold for the Long Term
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Financial Services Stocks Investing
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
